Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - naproxen, quantity: 250 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate; maize starch; purified talc; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica - treatment of rheumatoid arthritis, juvenile rheumatoid arthritis and osteoarthritis, ankylosing spondylitis; symptomatic treatment of primary dysmenorrhoea, relief of acute and/or chronic pain states in which there is an inflammatory component, and as an analgesic in acute migraine attack.

Australia - English - Department of Health (Therapeutic Goods Administration)

maxx pharma pty ltd - trastuzumab, quantity: 150 mg - powder - excipient ingredients: histidine; sorbitol; histidine hydrochloride monohydrate; macrogol 3350; sodium hydroxide; hydrochloric acid - ? early breast cancer,ogivri is indicated for the treatment of her2-positive early breast cancer following surgery, and in association with chemotherapy and, if applicable, radiotherapy.,? locally advanced breast cancer,ogivri is indicated for the treatment of her2-positive locally advanced breast cancer in combination with neoadjuvant chemotherapy followed by adjuvant ogivri.,? metastatic breast cancer,ogivri is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2:,a) as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease;,b) in combination with taxanes for the treatment of those patients who have not received chemotherapy for their metastatic disease; or,c) in combination with an aromatase inhibitor for the treatment of post-menopausal patients with hormone-receptor positive metastatic breast cancer.,? advanced gastric cancer,ogivri is indicated in combination with cisplatin and either capecitabine or 5-fu for the treatment of patients with her2 positive advanced adenocarcinoma of the stomach or gastro-oesophageal junction who have not received prior anti-cancer treatment for their metastatic disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

ecolab pty ltd - 9950 - disinfectant, hospital grade - other therapeutic

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agritrading pty limited - tebuconazole - suspension concentrate - tebuconazole triazole active 430.0 g/l - fungicide

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - perindopril erbumine, quantity: 4 mg; indapamide hemihydrate, quantity: 1.25 mg - tablet - excipient ingredients: sodium bicarbonate; microcrystalline cellulose; lactose; colloidal anhydrous silica; magnesium stearate - treatment of hypertension. treatment should not be initiated with this combination

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 50 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; sodium stearylfumarate; microcrystalline cellulose; light magnesium oxide - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium starch glycollate; sodium stearylfumarate; microcrystalline cellulose; allura red ac aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 100 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; light magnesium oxide; microcrystalline cellulose; sodium stearylfumarate; sunset yellow fcf aluminium lake; tartrazine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium stearylfumarate; sodium starch glycollate; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

fortun8 international trading co pty limited - ct772 - severe acute respiratory syndrome-associated coronavirus ivds - intended to detect the novel coronavirus sars-cov-2 that causes covid-19 from symptomatic individuals for self-testing by lay persons (nasal swab).